These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 10760492

  • 1. In vitro and in vivo m2 muscarinic subtype selectivity of some dibenzodiazepinones and pyridobenzodiazepinones.
    Cohen VI, Jin B, McRee RC, Boulay SF, Cohen EI, Sood VK, Zeeberg BR, Reba RC.
    Brain Res; 2000 Apr 10; 861(2):305-15. PubMed ID: 10760492
    [Abstract] [Full Text] [Related]

  • 2. A novel muscarinic receptor ligand which penetrates the blood brain barrier and displays in vivo selectivity for the m2 subtype.
    Gitler MS, Cohen VI, De la Cruz R, Boulay SF, Jin B, Zeeberg BR, Reba RC.
    Life Sci; 1993 Apr 10; 53(23):1743-51. PubMed ID: 8246670
    [Abstract] [Full Text] [Related]

  • 3. Autoradiographic evidence that QNB displays in vivo selectivity for the m2 subtype.
    McRee RC, Boulay SF, Sood VK, Cohen EI, Cohen VI, Gitler MS, Zeeberg BR, Gibson RE, Reba RC.
    Neuroimage; 1995 Mar 10; 2(1):55-62. PubMed ID: 9343590
    [Abstract] [Full Text] [Related]

  • 4. Characterization of in vivo brain muscarinic acetylcholine receptor subtype selectivity by competition studies against (R,S)-[125I]IQNB.
    Gitler MS, Boulay SF, Sood VK, McPherson DW, Knap FF, Zeeberg BR, Reba RC.
    Brain Res; 1995 Jul 31; 687(1-2):71-8. PubMed ID: 7583315
    [Abstract] [Full Text] [Related]

  • 5. Autoradiographic evidence that quinuclidinyl 4-(bromophenyl)-2-thienylglycolate (QBPTG) displays in vivo selectivity for the muscarinic m2 subtype.
    Boulay SF, Sood VK, Rayeq MR, McRee RC, Cohen EI, Cohen VI, Zeeberg BR, Reba RC.
    Neuroimage; 1995 Sep 31; 2(3):209-13. PubMed ID: 9343604
    [Abstract] [Full Text] [Related]

  • 6. Autoradiographic evidence that 3-quinuclidinyl-4-fluorobenzilate (FQNB) displays in vivo selectivity for the m2 subtype.
    Boulay SF, Sood VK, Rayeq MR, Cohen VI, Zeeberg BR, Reba RC.
    Neuroimage; 1996 Feb 31; 3(1):35-9. PubMed ID: 9345473
    [Abstract] [Full Text] [Related]

  • 7. Autoradiographic evidence that (R)-3-quinuclidinyl (S)-4-fluoromethylbenzilate ((R,S)-FMeQNB) displays in vivo selectivity for the muscarinic m2 subtype.
    Boulay SF, Sood VK, Rayeq MR, Zeeberg BR, Eckelman WC.
    Nucl Med Biol; 1996 Oct 31; 23(7):889-96. PubMed ID: 8971856
    [Abstract] [Full Text] [Related]

  • 8. In vivo autoradiographic competition studies of isomers of [125I]IQNP against QNB demonstrating in vivo m2 muscarinic subtype selectivity for QNB.
    Zeeberg BR, Boulay SF, Sood VK, Rayeq MR, Danesh RA, McPherson DW, Knapp FF.
    Recept Signal Transduct; 1997 Oct 31; 7(1):45-54. PubMed ID: 9285530
    [Abstract] [Full Text] [Related]

  • 9. [3H]QNB displays in vivo selectivity for the m2 subtype.
    Gitler MS, De la Cruz R, Zeeberg BR, Reba RC.
    Life Sci; 1994 Oct 31; 55(19):1493-508. PubMed ID: 7968217
    [Abstract] [Full Text] [Related]

  • 10. In vivo competition studies of Z-(-,-)-[125I]IQNP against 3-quinuclidinyl 2-(5-bromothienyl)-2-thienylglycolate (BrQNT) demonstrating in vivo m2 muscarinic subtype selectivity for BrQNT.
    Cohen VI, Zeeberg BR, Boulay SF, Sood VK, Rayeq MR, Danesh RA, McPherson DW, Reba RC.
    J Mol Neurosci; 1998 Aug 31; 11(1):1-9. PubMed ID: 9826782
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of stereoisomers of 4-fluoroalkyl analogues of 3-quinuclidinyl benzilate in in vivo competition studies for the M1, M2, and M3 muscarinic receptor subtypes in brain.
    Lee J, Paik CH, Kiesewetter DO, Park SG, Eckelman WC.
    Nucl Med Biol; 1995 Aug 31; 22(6):773-81. PubMed ID: 8535338
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the in vivo rat brain regional pharmacokinetics of [3H]QNB, (R,S)-[125I]-4IQNB, and (R,R)-[125I]-4IQNB binding to the muscarinic acetylcholine receptor in relationship to the regional subtype composition.
    Boulay SF, Gitler MS, Sood VK, Cohen VI, Zeeberg BR, Reba RC.
    Receptor; 1995 Aug 31; 5(4):207-18. PubMed ID: 8840399
    [Abstract] [Full Text] [Related]

  • 13. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ, Tran LP.
    J Pharmacol Exp Ther; 1990 Dec 31; 255(3):1148-57. PubMed ID: 2262898
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Binding of radioiodinated SPECT ligands to transfected cell membranes expressing single muscarinic receptor subtypes.
    Zeeberg BR, Gitler MS, Baumgold J, de la Cruz RA, Reba RC.
    Biochem Biophys Res Commun; 1991 Sep 16; 179(2):768-75. PubMed ID: 1898398
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.